« Previous
Next »
Medical Hypotheses
Volume 59, Issue 1
, Pages 98-100
, July 2002
Anergy and chemokine receptors
References
- . HIV and the transmembrane domain receptors. Pathobiology. 1996;64:171–179
- CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 1997;385:645–649
-
.
The HIV co-receptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Proc. Natl. Acad. Sci. USA. 1997;94:1925–1930
- . Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 1997;185:621–628
- The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382:833–835
- . Anergy, AIDS and tuberculosis. Med. Hypotheses. 1995;45:433–440
- . Anergy and human immunodeficiency virus infection. Med. Hypotheses. 2001;56:376–380
- . Anergy and acquired immune deficiency syndrome. Med. Hypotheses. 2001;56:250–255
- . T-Cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function. Immunol. Today. 1993;14:161–164
- . Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993;262:1011–1018
- . Apoptosis by death factor. Cell. 1997;88:355–365
-
.
Immunoglobulin VH3 gene products: natural ligands for HIV gp120.
Science. 1993;261:1558–1591
PII: S0306-9877(02)00118-4
« Previous
Next »
Medical Hypotheses
Volume 59, Issue 1
, Pages 98-100
, July 2002
